Chemical Compound

Ancriviroc

CAS Registry Number 370893-06-4
Ancriviroc chemical structure
Primary Record

Ancriviroc

Note: Only for scientific research or as raw materials for production.

In stock
2,474 g
Purity
98.8 %
CAS
370893-06-4

Compound Identifiers & Properties

CAS
370893-06-4
PubChem CID
9574343
SMILES
CCO/N=C(/C1CCN(CC1)C2(CCN(CC2)C(=O)C3=C(C=C[N+](=C3C)[O-])C)C)\C4=CC=C(C=C4)Br
Canonical SMILES
CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1

Names & Synonyms

  • Ancriviroc
  • SCH-C & AOP-RANTES
  • ancrivirocum
  • [3H]ancriviroc
  • SCH-C
  • Schering C
  • Ancriviroc [USAN]
  • SCH-C cpd
  • SCH C
  • SCH-351125
  • ANCRIVIROC [INN]
  • SCH-C AOP-RANTES
  • RefChem:915808
  • SCH 351125
  • SCH 351125 & AOP-RANTES
  • SCH 351125 (non-stereospecific)
  • SCH351125
  • AK671/SCH-C
  • CHEMBL78535
  • D07KVP
  • D0G6JE
  • 322WXU4AU2
  • SCH-C & PA14
  • GTPL802
  • GTPL804
  • CHEMBL336672
  • SCHEMBL2939134
  • [3H]Sch-351125
  • 370893-06-4
  • SCHEMBL29357632
  • SCH 351125 AOP-RANTES
  • [3H]SCH 351125
  • SC-351125
  • BDBM50104931
  • CID9574343
  • CID:9574343
  • SID:53787069
  • LS-183687
  • J1.655.006J
  • [4-[4-[(Z)-C-(4-bromophenyl)-N-ethoxycarbonimidoyl]piperidin-1-yl]-4-methylpiperidin-1-yl]-(2,4-dimethyl-1-oxidopyridin-1-ium-3-yl)methanone
  • 305792-46-5
  • C438583
  • L023973
  • A1243018
  • Q27074462
  • [4-[4-[C-(4-bromophenyl)-N-ethoxy-carbonimidoyl]-1-piperidyl]-4-methyl-1-piperidyl]-(2,4-dimethyl-1-oxido-pyridin-3-yl)methanone
  • 4-((4-bromophenyl)-(ethoxyimino)methyl)-1'-((2,4-dimethyl-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine N-oxide
  • Methanone, (4-bromophenyl)(1'-((2,4-dimethyl-3-pyridinyl)carbonyl)-4'-methyl(1,4'-bipiperidin)-4-yl)-, O-ethyloxime, (Z)-, N1-oxide & AOP-RANTES
  • Methanone, (4-bromophenyl)(1'-((2,4-dimethyl-3-pyridinyl)carbonyl)-4'-methyl(1,4'-pipiperidin)-4-yl)-, O-ethyloxime, N1-oxide
  • 3,4-Bis((benzyloxy)carbonyl)piperazine-2-carboxylic acid
  • (2,4-Dimethyl-1-oxy-pyridin-3-yl)-(4'-methyl-[1,4']bipiperidinyl-1'-yl)-methanone
  • 1'-[(2,4-Dimethyl-1-oxidopyridin-3-yl)carbonyl]-4'-methyl-1,4'-bipiperidine
  • [4-[4-[(Z)-C-(4-bromophenyl)-N-ethoxy-carbonimidoyl]-1-piperidyl]-4-methyl-1-piperidyl]-(2,4-dimethyl-1-oxido-pyridin-1-ium-3-yl)methanone
  • Methanone, (4-bromophenyl)[1'-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4'-methyl[1,4'-bipiperidin]-4-yl]-, O-ethyloxime, (Z)-, N1-oxide
  • Methanone, (4-bromophenyl)[1'-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4'-methyl[1,4'-bipiperidin]-4-yl]-, O-ethyloxime, (Z)-, N1-oxide & AOP-RANTES
  • Methanone, (4-bromophenyl)[1'-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4'-methyl[1,4'-bipiperidin]-4-yl]-, O-ethyloxime, (Z)-, N1-oxide & PRO 140 (Anti-CCR5 monoclonal antibody)
  • (1,4'-BIPIPERIDINE)-4-METHANIMINE, .ALPHA.-(4-BROMOPHENYL)-1'-((2,4-DIMETHYL-1-OXIDO-3-PYRIDINYL)CARBONYL)-N-ETHOXY-4'-METHYL-, (.ALPHA.Z)-
  • (4-(4-((Z)-C-(4-bromophenyl)-N-ethoxycarbonimidoyl)piperidin-1-yl)-4-methylpiperidin-1-yl)-(2,4-dimethyl-1-oxidopyridin-1-ium-3-yl)methanone
  • (4-{(4-Bromo-phenyl)-[(E)-ethoxyimino]-methyl}-4''''-methyl-[1,4'''']bipiperidinyl-1''''-yl)-(2,4-dimethyl-1-oxy-pyridin-3-yl)-methanone
  • (4-{(4-Bromo-phenyl)-[(Z)-ethoxyimino]-methyl}-4''''''''-methyl-[1,4'''''''']bipiperidinyl-1''''''''-yl)-(2,4-dimethyl-1-oxy-pyridin-3-yl)-methanone
  • (4-{(4-Bromo-phenyl)-[(Z)-ethoxyimino]-methyl}-4''-methyl-[1,4'']bipiperidinyl-1''-yl)-(2,4-dimethyl-1-oxy-pyridin-3-yl)-methanone
  • (Z)-3-(4-((4-Bromophenyl)(ethoxyimino)methyl)-4'-methyl-[1,4'-bipiperidine]-1'-carbonyl)-2,4-dimethylpyridine 1-oxide
  • {4-[(4-Bromo-phenyl)-ethoxyimino-methyl]-4''''-methyl-[1,4'''']bipiperidinyl-1''''-yl}-(2,4-dimethyl-1-oxy-pyridin-3-yl)-methanone
  • {4-[(Z)-(4-Bromophenyl)(ethoxyimino)methyl]-4'-methyl-1,4'-bipipe ridin-1'-yl}(2,4-dimethyl-1-oxido-3-pyridinyl)methanone
  • 2,4-Dimethyl-3-[[4-[alpha-(ethoxyimino)-4-bromobenzyl]-4 -methyl-1,4 -bipiperidine-1 -yl]carbonyl]pyridine 1-oxide
  • 3-(4-((4-bromophenyl)(ethoxyimino)methyl)-4''''-methyl-1,4''''-bipiperidine-1''''-carbonyl)-1,2,4-trimethylpyridinium
  • 3-[(4-{4-[(1Z)-(4-bromophenyl)(ethoxyimino)methyl]piperidin-1-yl}-4-methylpiperidin-1-yl)carbonyl]-2,4-dimethylpyridin-1-ium-1-olate
  • 3-{4-[(4-bromophenyl)(ethoxyimino)methyl]-4'-methyl-[1,4'-bipiperidine]-1'-carbonyl}-2,4-dimethylpyridin-1-ium-1-olate
  • 4-((Z)-(4-BROMOPHENYL)(ETHOXYIMINO)METHYL)-1'-((2,4-DIMETHYL-1-OXIDOPYRIDIN-3-YL)CARBONYL)-4'-METHYL(1,4'-BIPIPERIDINYL)
  • 4-[alpha-(Ethoxyimino)-4-bromobenzyl]-4 -methyl-1 -[(2,4-dimethylpyridine 1-oxide)-3-ylcarbonyl]-1,4 -bi(piperidine)
  • Methanone, (4-bromophenyl)(1'-((2,4-dimethyl-3-pyridinyl)carbonyl)-4'-methyl(1,4'-bipiperidin)-4-yl)-, O-ethyloxime, (Z)-, N1-oxide AOP-RANTES
  • Methanone,(4-bromophenyl)[1'-[(2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-4'-methyl[1,4'-bipiperidin]-4-yl]-,1-(O-ethyloxime), (1Z)-